NP wasn't sure if you guys were aware this one has catalyst on top of catalyst, for days, everything thing going for it Edleman (Buffet of BioTechs) in it for 7.7% three analyst firms totally on board loving the thing and all bases covered, winner winner chicken dinner IMHO.